Cargando…
Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model
Plasmids, which are currently used in interleukin 12 (IL-12) gene electrotransfer (GET) clinical trials in the USA, contain antibiotic resistance genes and are thus, according to the safety recommendation of the European Medicines Agency (EMA), not suitable for clinical trials in the EU. In the curr...
Autores principales: | Kamensek, Urska, Tesic, Natasa, Sersa, Gregor, Cemazar, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876635/ https://www.ncbi.nlm.nih.gov/pubmed/29495490 http://dx.doi.org/10.3390/cancers10030060 |
Ejemplares similares
-
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model
por: Kamensek, Urska, et al.
Publicado: (2018) -
Maintenance and gene electrotransfer efficiency of antibiotic resistance gene-free plasmids encoding mouse, canine and human interleukin-12 orthologues
por: Kamensek, Urska, et al.
Publicado: (2022) -
Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model
por: Kamensek, Urska, et al.
Publicado: (2013) -
Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma
por: Lampreht Tratar, Ursa, et al.
Publicado: (2017) -
Electrotransfer of Different Control Plasmids Elicits Different Antitumor Effectiveness in B16.F10 Melanoma
por: Bosnjak, Masa, et al.
Publicado: (2018)